Emilie Coueignoux is Vice President of Business Development at GentiBio. Emilie was previously at Seagen, a global oncology company, where she started in Commercial organization with the Global Market Insights team before transitioning to Corporate Development. As Senior Director of Corporate Development, she played leading roles in the acquisition of Cascadian Therapeutics as well as collaboration agreements with BeiGene and Merck. Prior to Seagen, she was a consultant in L.E.K.’s life science practice, working in the Boston and Shanghai offices. Emilie has an MBA from The Wharton School at the University of Pennsylvania. In her free time, she likes to travel with her husband and daughter, and discover new local hikes in the Pacific Northwest.
Emilie Coueignoux, MBA
VP, Business Development